연구동향 분석

조현병 환자에서 아미설프라이드에 의한 체중증가와 도파민 D2 수용체 유전자다형성의(rs1800497) 연관성

서민재(Min Jae Seo) 우정민(Jung Min Woo) 이종훈(Jong Hun Lee) 최태영(Tae Young Choi) 김지현 ( Jihyun Kim ) 최성민(Sung Min Choi) 2014년

논문상세정보
인용/피인용
' 조현병 환자에서 아미설프라이드에 의한 체중증가와 도파민 D2 수용체 유전자다형성의(rs1800497) 연관성' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • amisulpride
  • drd2gene
  • polymorphisms
  • weight gain
  • 도파민d2수용체유전자
  • 아미설프라이드
  • 유전자다형성
  • 체중증가프
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,366 0

0.0%

' 조현병 환자에서 아미설프라이드에 의한 체중증가와 도파민 D2 수용체 유전자다형성의(rs1800497) 연관성' 의 참고문헌

  • 한국인 정신분열병 환자에서 항정신병 약물에 의한 체중 증가와 도파민 D2, D3 및 D4 수용체 유전자 다형성
    김희철 대한정신약물학회지 18 (5) : 299 ~ 307 [2007]
  • What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
    Berridge KC Brain Res Brain Res Rev 28 : 309 ~ 369 [1998]
  • Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons : one-year analysis
    Strassnig M Schizophr Res 93 : 90 ~ 98 [2007]
  • The impact of weight gain on quality of life among persons with schizophrenia
    Allison DB Psychiatr Serv 54 : 565 ~ 567 [2003]
  • The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP
    Grandy DK Am J Hum Genet 45 : 778 ~ 785 [1989]
  • The etiology of obesity: relative contribution of metabolic factors, diet, and physical activity
    Weinsier RL Am J Med 105 : 145 ~ 150 [1998]
  • The dopamine D2 receptor(DRD2)gene : a genetic risk factor in smoking
    Comings DE Pharmacogenetics 6 : 73 ~ 79 [1996]
  • The dopamine D2 receptor(DRD2)as a major gene in obesity and height
    Comings DE Biochem Med Metab Biol 50 : 176 ~ 185 [1993]
  • The DRD2 gene in psychiatric and neurological disorders and its phenotypes
    Noble EP Pharmacogenomics 1 : 309 ~ 333 [2000]
  • The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
    Pohjalainen T Mol Psychiatry 3 : 256 ~ 260 [1998]
  • Targeting 5-HT receptors for the treatment of obesity
    Sargent BJ Curr Opin Pharmacol 11 : 52 ~ 58 [2011]
  • Systematic analysis of dopamine receptor genes(DRD1-DRD5)in antipsychotic-induced weight gain
    Muller DJ Pharmacogenomics J 12 : 156 ~ 164 [2012]
  • Schizophrenia and obesity : impact of antipsychotic medications
    Wirshing DA J Clin Psychiatry 65 (Suppl 18) : 13 ~ 26 [2004]
  • Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers
    Epstein LH Am J Clin Nutr 80 : 82 ~ 88 [2004]
  • Psychopharmacological profile of amisulpride : an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity
    Perrault G J Pharmacol Exp Ther 280 : 73 ~ 82 [1997]
  • Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
    Jonsson EG Mol Psychiatry 4 : 290 ~ 296 [1999]
  • Pharmacogenetics of antipsychoticinduced weight gain : review and clinical implications
    Lett TA Mol Psychiatry 17 : 242 ~ 266 [2012]
  • Obesity as a risk factor for antipsychotic noncompliance
    Weiden PJ Schizophrenia Research 66 : 51 ~ 57 [2004]
  • Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse
    Salamone JD J Pharmacol Exp Ther 305 : 1 ~ 8 [2003]
  • No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response
    Zhang ZJ Acta Pharmacol Sin 24 : 235 ~ 240 [2003]
  • Neuroleptic-induced"anhedonia"in rats : pimozide blocks reward quality of food
    Wise RA Science 201 : 262 ~ 264 [1978]
  • Major attenuation of food reward with performance-sparing doses of pimozide in the rat
    Wise RA Can J Psychol 32 : 77 ~ 85 [1978]
  • Histamine in the nervous system
    Haas HL Physiol Rev 88 : 1183 ~ 1241 [2008]
  • Half a century of antipsychotics and still a central role for dopamine D2 receptors
    Kapur S Prog Neuropsychopharmacol Biol Psychiatry 27 : 1081 ~ 1090 [2003]
  • Food reward : brain substrates of wanting and liking
    Berridge KC Neurosci Biobehav Rev 20 : 1 ~ 25 [1996]
  • Food reinforcement, the dopamine D2receptor genotype, and energy intake in obese and nonobese humans
    Epstein LH Behav Neurosci 121 : 877 ~ 886 [2007]
  • Food reinforcement and eating : a multilevel analysis
    Epstein LH Psychol Bull 133 : 884 ~ 906 [2007]
  • Food hedonics and reinforcement as determinants of laboratory food intake in smokers
    Epstein LH Physiol Behav 81 : 511 ~ 517 [2004]
  • Effects of reinforcer sweet-ness and the D2/D3 antagonist raclopride on progressive ratio operant performance
    Cheeta S Behav Pharmacol 6 : 127 ~ 132 [1995]
  • Drugs of abuse: anatomy, pharmacology and function of reward pathways
    Koob GF Trends Pharmacol Sci 13 : 177 ~ 184 [1992]
  • Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task
    Salamone JD Psychopharmacology 160 : 371 ~ 380 [2002]
  • DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia
    Lencz T Pharmacogenet Genomics 20 : 569 ~ 572 [2010]
  • D2 dopamine receptor gene(DRD2)Taq1 A polymorphism : reduced dopamine D2 receptor binding in the human striatum associated with the A1allele
    Thompson J Pharmacogenetics 7 : 479 ~ 484 [1997]
  • D2 dopamine receptor gene and cigarette smoking: a reward gene?
    Noble EP Med Hypotheses 42 : 257 ~ 260 [1994]
  • Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report
    National Institutes of Health Obes Res 6 (Suppl 2) : 51S ~ 209S [1998]
  • Brain dopamine and obesity
    Wang GJ Lancet 357 : 354 ~ 357 [2001]
  • Atypical antipsychotics and weight gain--a systematic review
    Taylor DM Acta Psychiatr Scand 101 : 416 ~ 432 [2000]
  • Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptorbinding characteristics
    Ritchie T Neurochem Res 28 : 73 ~ 82 [2003]
  • Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA with obesity or type 2 diabetes mellitus in Pima Indians
    Jenkinson CP Int J Obes Relat Metab Disord 24 : 1233 ~ 1238 [2000]
  • Antipsychotic-induced weight gain : a comprehensive research synthesis
    Allison DB Am J Psychiatry 156 : 1686 ~ 1696 [1999]
  • Antipsychotic-associated weight gain and clinical outcome parameters
    Blin O J Clin Psychiatry 62 (Suppl 7) : 11 ~ 21 [2001]
  • Antipsychotic drugs and obesity
    Correll CU Trends Mol Med 17 : 97 ~ 107 [2011]
  • Allelic association of the D2 dopamine receptor gene with cocaine dependence
    Noble EP Drug Alcohol Depend 33 : 271 ~ 285 [1993]
  • A Ser311Cys mutation in the human dopamine receptor D2 gene is associated with reduced energy expenditure
    Tataranni PA Diabetes 50 : 901 ~ 904 [2001]
  • A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia
    Lee SJ Clin Drug Investig 32 : 735 ~ 745 [2012]